Auxilium to Buy QLT in Latest Drug Company Tax Inversion

Auxilium Pharmaceuticals Inc. agreed to take control of biotechnology firm QLT Inc. in a $345 million stock deal that will re-domicile the company in Canada and give Auxilium new experimental eye drug products.

To continue reading this article you must be a Bloomberg Professional Service Subscriber.